AAPL 204.56 2.4131% MSFT 377.02 2.7807% NVDA 104.16 5.3292% GOOGL 155.05 2.3635% GOOG 157.9 2.5991% AMZN 182.212 5.2154% META 522.065 4.3546% AVGO 179.3019 5.7329% LLY 821.86 -0.6864% TSLA 256.44 7.7615% TSM 157.66 4.1347% V 335.57 1.2583% JPM 241.75 2.6147% UNH 433.99 1.5942% NVO 61.4 2.4871% WMT 94.85 0.0% LVMUY 112.1 2.1139% XOM 107.555 -0.6879% LVMHF 571.0 2.589% MA 531.72 0.8325%
Company Overview: Laramide Resources Ltd. (TSX: LAM) is a Canadian company specializing in the exploration and development of high-quality uranium assets in Australia and the United States. Their portfolio includes advanced projects selected for significant production potential. PAVmed Inc. (NASDAQ: PAVM) is a diversified medical technology company focused on rapidly advancing a broad pipeline of innovative products from concept to commercialization. The Report covers the Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendations on these two stocks.
Global Markets Wrap-Up
On February 27, 2025, the S&P 500 closed at 5,861.57, posting a week-to-date (WTD) loss of 2.03%. The NASDAQ Composite, heavily weighted with technology stocks, experienced a sharper decline of 5.02% for the week, finishing at 18,544.42. Meanwhile, the Russell 2000 closed at 2,139.66, reflecting a WTD drop of approximately 2.54%.
Considering the Canadian market, the benchmark S&P/TSX Venture Composite Index (TSX: ^JX) started the week on a negative note and continued the momentum. On February 27, 2025, the index closed at 615.84, reflecting a week-to-date (WTD) decline of 2.97%. While the Real Estate and consumer cyclicals sectors provided some upward momentum, the broader market faced challenges. technology, basic materials, financials, energy, consumer non-cyclicals, industrials, and healthcare underperformed on Thursday, contributing to the overall market weakness.
Xxxxxx Xxxxxx Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Enter your details below and our team will help you to decide if this product is best for you.
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.
US
CA
NZ
UK
AU
IND
Please wait processing your request...